Cookie Consent by FreePrivacyPolicy.com
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

31.05.2023
Genekam developed PCR kits for Candida auris.

Latest News:

04.05.2023
Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!

  • ++BREAKING NEWS (26.05.2020)++

    Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.

  • MEDICA 2023

    Visit us on Medica, Duesseldorf. 13.-16. November 2023

Enzyme linked immunospot ( ELISA )

It is possible to obtain an immune response from T cells against the invading pathogens as these cells start secreting some enzymes (cytokines) like interferon gamma, if they are stimulated with a pathogen specific antigen or cocktail of antigens. The released cytokines can be measured in the form of spots on paper. These spots are generated from cells producing these cytokines. As the number of such spots or colonies can be counted, hence it is possible to generate quantitative data. This data can be compared between the different samples and different stages of disease. This method has been applied to detect acute and chronic stages (latent form) caused through different pathogens like Mycobacterium tuberculosis, Borrelia burgdorferi, Chlamydia trachomatis etc), Genekam is in the process of developing such tests for different pathogens, therefore we have decided to offer at present different components as there are many laboratories, which have developed in house methods and they may need only some components to run their assays. Genekam is developing such ready to use assays, once they will be ready, they will be offered as complete solutions.
TOP